M. Benevolo et al., DIAGNOSTIC AND PROGNOSTIC VALUE OF PERITONEAL IMMUNOCYTOLOGY IN GASTRIC-CANCER, Journal of clinical oncology, 16(10), 1998, pp. 3406-3411
Purpose: Among the clinical factors with ct pivotal role in the predic
tion of outcome for patients with gastric cancer, intraperitoneal (19)
microscopic dissemination may represent an important cause of recurre
nces, even in the early stages of the disease. In this context, the cy
tologic examination of intraoperative peritoneal washings may be essen
tial to identify metastatic free cells, although a number of false-neg
ative cases may be encountered. Patients and Methods: To determine whe
ther immunocytochemical (ICC) methods that used ct panel of three mono
clonal antibodies (MoAbs), B72.3, AR3, and BD5, directed to gastric ca
ncer-associated antigens can improve peritoneal cytology by providing
more accurate prognostic indications, we immunocytochemically and morp
hologically evaluated 144 peritoneal washings sampled from patients su
rgically treated for gastric cancer. Results: The ICC analysis allowed
the identification of metastatic free peritoneal cells in 35% of the
patients, with a 14% improvement over routine cytopathology (P < .0001
). furthermore, a 54 month survival analysis by Kaplan-Meier curves sh
owed a statistically significant decrease in overall survival (OS) in
patients with stages I through III disease with peritoneal microscopic
disease detected morphologically and/or by ICC at the time of the pri
mary surgery. Conclusion: Our data indicate that the use of a combinat
ion of selected MoAbs may allow the identification of cytologically fa
lse negative cases that provide valuable prognostic information. This
may be useful to stratify patients on more adequate therapeutic trials
. (C) 1998 by American Society of Clinical Oncology.